Author:
Halpern Rachel,Agarwal Sonalee,Borton Leigh,Oneacre Kathy,Lopez-Bresnahan Maria V.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference49 articles.
1. National Multiple Sclerosis Society. Just the facts. 2010. Available at: http://www.nationalmssociety.org/about-multiple-sclerosis/what-we-know-aboutms/what-is-ms/index.aspx. Accessed March 15, 2011.
2. Bainbridge JL, Rieckmann P. Multiple sclerosis. In: DiPiro JT, Talbert R, Yee G, Matzke G, eds. Pharmacotherapy: A Pathophysiologic Approach. New York: McGraw-Hill Medical; 2008: 913–926.
3. Havrdova E, Galetta S, Stefoski D, Comi G. Freedom from disease activity in multiple sclerosis. Neurology 2010;74(suppl. 3):S3–S7.
4. IFNB Multiple Sclerosis Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology 1993;43:655–661.
5. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol 1996;39:285–294.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献